WallStreetZenWallStreetZen

NASDAQ: BSEM
Biostem Technologies Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their BSEM stock forecasts and price targets.

Forecast return on equity

Is BSEM forecast to generate an efficient return?

Company
N/A
Industry
76.32%
Market
171.51%

Forecast return on assets

Is BSEM forecast to generate an efficient return on assets?

Company
N/A
Industry
38.75%

BSEM earnings per share forecast

What is BSEM's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$1.99
Avg 2 year Forecast
-$0.26
Avg 3 year Forecast
$0.64

BSEM revenue forecast

What is BSEM's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$29.6M
Avg 2 year Forecast
$72.1M
Avg 3 year Forecast
$102.6M

BSEM vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BSEM$3.61N/AN/A
HRTX$0.32N/AN/AHold
DWTX$1.84$12.00+552.17%Buy
TENX$1.62$19.71+1,116.91%Strong Buy
BOLD$2.75N/AN/A
View Top Biotech Stocks

Biostem Technologies Stock Forecast FAQ

What is BSEM's earnings growth forecast for 2026-2028?

(NASDAQ: BSEM) Biostem Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.99%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.88%.

Biostem Technologies's earnings in 2026 is N/A.On average, 3 Wall Street analysts forecast BSEM's earnings for 2026 to be -$33,781,289, with the lowest BSEM earnings forecast at -$32,456,533, and the highest BSEM earnings forecast at -$34,774,857. On average, 3 Wall Street analysts forecast BSEM's earnings for 2027 to be -$4,330,935, with the lowest BSEM earnings forecast at -$4,161,094, and the highest BSEM earnings forecast at -$4,458,315.

In 2028, BSEM is forecast to generate $10,913,955 in earnings, with the lowest earnings forecast at $10,485,957 and the highest earnings forecast at $11,234,954.

If you're new to stock investing, here's how to buy Biostem Technologies stock.

What is BSEM's revenue growth forecast for 2026-2028?

(NASDAQ: BSEM) Biostem Technologies's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 33.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.45%.

Biostem Technologies's revenue in 2026 is N/A.On average, 3 Wall Street analysts forecast BSEM's revenue for 2026 to be $502,456,342, with the lowest BSEM revenue forecast at $482,754,836, and the highest BSEM revenue forecast at $517,232,472. On average, 3 Wall Street analysts forecast BSEM's revenue for 2027 to be $1,224,686,382, with the lowest BSEM revenue forecast at $1,176,655,469, and the highest BSEM revenue forecast at $1,260,709,567.

In 2028, BSEM is forecast to generate $1,742,394,408 in revenue, with the lowest revenue forecast at $1,674,050,562 and the highest revenue forecast at $1,793,686,260.

What is BSEM's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: BSEM) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 38.75%.

What is BSEM's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: BSEM) Biostem Technologies's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that BSEM's EPS will be -$1.99 for 2026, with the lowest EPS forecast at -$1.91, and the highest EPS forecast at -$2.05. On average, analysts forecast that BSEM's EPS will be -$0.26 for 2027, with the lowest EPS forecast at -$0.25, and the highest EPS forecast at -$0.26. In 2028, BSEM's EPS is forecast to hit $0.64 (min: $0.62, max: $0.66).

What is BSEM's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: BSEM) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.